Krystal Biotech, Inc. (KRYS)
NASDAQ·Healthcare·Biotechnology
$328.38
+4.99%
Mkt Cap $9.21B
Analyst Ratings
Buy
13
Hold
0
Sell
0
Price Target (14 analysts)
$336.40
Range $300.00 – $371.00
Implied Upside
+2.4%
Consensus $336.40 vs current $328.38
NASDAQ·Healthcare·Biotechnology
$328.38
+4.99%
Mkt Cap $9.21B
Buy
13
Hold
0
Sell
0
Price Target (14 analysts)
$336.40
Range $300.00 – $371.00
+2.4%
Consensus $336.40 vs current $328.38